Tak­ing on biode­fense threats, an­tibi­otics mak­er Spero inks $54M in gov­ern­ment deals

Cam­bridge, Mass­a­chu­setts start­up Spero Ther­a­peu­tics is join­ing forces with US de­fense or­ga­ni­za­tions to see if their in­ves­ti­ga­tion­al an­tibi­ot­ic could be use­ful against biode­fense threats. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.